Atlas Trials

A Phase II Study of Axitinib in Metastatic Non-clear Cell Renal Cell Carcinoma Patients Previously Treated With Temsirolimus

Clinical trial NCT01798446 · COMPLETED

Trial details

NCT number
NCT01798446
Sponsor
Seoul National University Hospital
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Renal Cell CarcinomaNonclear CellTemsirolimus Resistance
Start date
2013-02-01
Primary completion
2015-06-01
Enrollment
41

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.